<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095674/" ref="ordinalpos=235&amp;ncbi_uid=3490074&amp;link_uid=PMC3095674" image-link="/pmc/articles/PMC3095674/figure/F4/" class="imagepopup">Figure 4. CsA activates TGFβ activated kinase 1 (TAK1) <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>.  From: Procarcinogenic Effects of Cyclosporine A are Mediated through the Activation of TAK1/TAB1 <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">Summary of the cascades of events triggered by CsA. .CsA enhances TAK1 by activating TGFβ-dependent signaling . CsA also augments the expression of upstream kinases ZMP and AMPK in addition to IRAK. The enhancement in the expression/activity of these signaling proteins contributes to MAP kinase and NFkB activation, which together triggers proliferation, reduced apoptosis and enhanced angiogenesis.</div></div>